BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 22154102)

  • 1. [Guillain-Barré syndrome in a child with normal tendon reflexes].
    Tellier S; Gerdelat-Mas A; Karsenty C; Cancès C; Tison C; Chaix Y; Cheuret E
    Arch Pediatr; 2012 Jan; 19(1):51-4. PubMed ID: 22154102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
    Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
    Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a.
    Tatsumoto M; Koga M; Gilbert M; Odaka M; Hirata K; Kuwabara S; Yuki N
    J Neuroimmunol; 2006 Aug; 177(1-2):201-8. PubMed ID: 16844234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case with upper limb dominant Guillain-Barré syndrome and serum IgG anti-GT1a antibodies: sparing oropharyngeal palsy].
    Ogawa K; Hoshino H; Takagi M; Mizoi Y; Irie S; Saito T
    Rinsho Shinkeigaku; 2001 Oct; 41(10):679-82. PubMed ID: 11993188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal profile of anti-ganglioside antibodies and their relation to clinical parameters and treatment in Guillain-Barré syndrome.
    Press R; Matá S; Lolli F; Zhu J; Andersson T; Link H
    J Neurol Sci; 2001 Sep; 190(1-2):41-7. PubMed ID: 11574105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GM1/GalNAc-GD1a complex: a target for pure motor Guillain-Barre syndrome.
    Kaida K; Sonoo M; Ogawa G; Kamakura K; Ueda-Sada M; Arita M; Motoyoshi K; Kusunoki S
    Neurology; 2008 Nov; 71(21):1683-90. PubMed ID: 19015484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ataxic form of Guillain-Barré syndrome associated with anti-GD1b IgG antibody].
    Ichikawa H; Susuki K; Yuki N; Kawamura M
    Rinsho Shinkeigaku; 2001 Aug; 41(8):523-5. PubMed ID: 11889840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Axonal Guillain-Barré syndrome: concepts and controversies.
    Kuwabara S; Yuki N
    Lancet Neurol; 2013 Dec; 12(12):1180-8. PubMed ID: 24229616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Case of pure motor Guillain-Barré syndrome with motor conduction block and anti-GM1/GalNAc-GD1a antibody].
    Ogawa G; Kaida K; Shiozaki Y; Araki M; Kimura F; Kamakura K
    Rinsho Shinkeigaku; 2009 Aug; 49(8):488-92. PubMed ID: 19827599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebellar ataxia and acute motor axonal neuropathy associated with Anti GD1b and Anti GM1 antibodies.
    Bae JS; Kim BJ
    J Clin Neurosci; 2005 Sep; 12(7):808-10. PubMed ID: 16054817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GQ1b antibody testing in Guillain-Barre syndrome and variants.
    Chaudhry F; Gee KE; Vaphiades MS; Biller J; Jay W
    Semin Ophthalmol; 2006; 21(4):223-7. PubMed ID: 17182410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns and serial changes in electrodiagnostic abnormalities of axonal Guillain-Barré syndrome.
    Hiraga A; Kuwabara S; Ogawara K; Misawa S; Kanesaka T; Koga M; Yuki N; Hattori T; Mori M
    Neurology; 2005 Mar; 64(5):856-60. PubMed ID: 15753422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan.
    Ogawara K; Kuwabara S; Mori M; Hattori T; Koga M; Yuki N
    Ann Neurol; 2000 Oct; 48(4):624-31. PubMed ID: 11026446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective study on anti-ganglioside antibodies in childhood Guillain-Barré syndrome.
    Schessl J; Koga M; Funakoshi K; Kirschner J; Muellges W; Weishaupt A; Gold R; Korinthenberg R
    Arch Dis Child; 2007 Jan; 92(1):48-52. PubMed ID: 16920757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Animal model of axonal Guillain-Barré syndrome induced by sensitization with GM1 ganglioside.
    Yuki N; Yamada M; Koga M; Odaka M; Susuki K; Tagawa Y; Ueda S; Kasama T; Ohnishi A; Hayashi S; Takahashi H; Kamijo M; Hirata K
    Ann Neurol; 2001 Jun; 49(6):712-20. PubMed ID: 11409422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features and response to treatment in Guillain-Barré syndrome associated with antibodies to GM1b ganglioside.
    Yuki N; Ang CW; Koga M; Jacobs BC; van Doorn PA; Hirata K; van der Meché FG
    Ann Neurol; 2000 Mar; 47(3):314-21. PubMed ID: 10716250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of anti-ganglioside antibodies in Guillain-Barré syndrome and its variants by the agglutination assay.
    Alaedini A; Briani C; Wirguin I; Siciliano G; D'Avino C; Latov N
    J Neurol Sci; 2002 Apr; 196(1-2):41-4. PubMed ID: 11959155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous spectrum of pharyngeal-cervical-brachial variant of Guillain-Barré syndrome.
    Nagashima T; Koga M; Odaka M; Hirata K; Yuki N
    Arch Neurol; 2007 Oct; 64(10):1519-23. PubMed ID: 17923636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serologic marker of acute motor axonal neuropathy in childhood.
    Nishimoto Y; Susuki K; Yuki N
    Pediatr Neurol; 2008 Jul; 39(1):67-70. PubMed ID: 18555178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous immunoglobulins neutralize blocking antibodies in Guillain-Barré syndrome.
    Buchwald B; Ahangari R; Weishaupt A; Toyka KV
    Ann Neurol; 2002 Jun; 51(6):673-80. PubMed ID: 12112071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.